CONMED Shares Owned By Institutions vs. Price To Earning
| CNMD Stock | USD 62.15 0.16 0.26% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.42 | 0.5182 |
|
|
For CONMED profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CONMED to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CONMED utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CONMED's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CONMED over time as well as its relative position and ranking within its peers.
CONMED |
CONMED's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.233 | Dividend Share 0.8 | Earnings Share 3.14 | Revenue Per Share 41.468 | Quarterly Revenue Growth 0.045 |
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CONMED Price To Earning vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CONMED's current stock value. Our valuation model uses many indicators to compare CONMED value to that of its competitors to determine the firm's financial worth. CONMED is rated fourth in shares owned by institutions category among its peers. It is rated third in price to earning category among its peers reporting about 1.89 of Price To Earning per Shares Owned By Institutions. Comparative valuation analysis is a catch-all technique that is used if you cannot value CONMED by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CONMED Price To Earning vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
CONMED |
| = | 99.44 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
CONMED |
| = | 188.03 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CONMED Price To Earning Comparison
CONMED is currently under evaluation in price to earning category among its peers.
CONMED Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CONMED, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CONMED will eventually generate negative long term returns. The profitability progress is the general direction of CONMED's change in net profit over the period of time. It can combine multiple indicators of CONMED, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -50.2 M | -47.7 M | |
| Operating Income | 130.8 M | 137.3 M | |
| Income Before Tax | 80.8 M | 84.9 M | |
| Total Other Income Expense Net | -50 M | -47.5 M | |
| Net Income | 64.5 M | 67.7 M | |
| Income Tax Expense | 16.4 M | 17.2 M | |
| Net Loss | -72.5 M | -68.9 M | |
| Net Income From Continuing Ops | 58 M | 60.9 M | |
| Non Operating Income Net Other | -100.8 M | -95.8 M | |
| Interest Income | 49.1 M | 51.6 M | |
| Net Interest Income | -39.7 M | -41.7 M | |
| Change To Netincome | 149.7 M | 157.2 M | |
| Net Income Per Share | 2.10 | 2.21 | |
| Income Quality | 1.94 | 1.85 | |
| Net Income Per E B T | 0.80 | 0.62 |
CONMED Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CONMED. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CONMED position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CONMED's important profitability drivers and their relationship over time.
Use CONMED in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CONMED position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will appreciate offsetting losses from the drop in the long position's value.CONMED Pair Trading
CONMED Pair Trading Analysis
The ability to find closely correlated positions to CONMED could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CONMED when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CONMED - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CONMED to buy it.
The correlation of CONMED is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CONMED moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CONMED moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CONMED can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CONMED position
In addition to having CONMED in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 55 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
To fully project CONMED's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CONMED at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CONMED's income statement, its balance sheet, and the statement of cash flows.